| Quantity | 5 mL, 25 mL | 1 mg | 100 µ, g, 500 µ, g, 1 mg | 100 mg, 250 mg, 500 mg, 1 g, 5 g, 10 g, 25 g | 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| Description | MCE Q Agarose HP is a high-resolution strong anion exchanger formed by covalently coupling quaternary ammonium (Q) groups to agarose. This medium offers high binding capacity, high specificity, and excellent ligand stability, making it suitable for both laboratory-scale and large-scale industrial MCE Q Agarose HP is a high-resolution strong anion exchanger formed by covalently coupling quaternary ammonium (Q) groups to agarose. This medium offers high binding capacity, high specificity, and excellent ligand stability, making it suitable for both laboratory-scale and large-scale industrial purification applications... Read More | Ceramide 1-phosphate is a bioactive lipid and one of the key components of sphingolipids. Ceramide 1-phosphate playing diverse roles in cellular behaviors such as cell differentiation, migration, proliferation and death[1] | Defensin HNP-1 human TFA is a Human neutrophil peptides (HNPs), involved in endothelial cell dysfunction at the time of early atherosclerotic development. Defensin HNP-1 human TFA exhibits broad antimicrobial and anti-leishmanial activities[1][2] | Pepsin is the major pig and human gastric proteases, it is a pepsin-like minor gastric proteolytic enzymes. Pepsin contributes to proteolysis of food proteins in the vertebrate stomach[1][2] | Survodutide (BI 456906) TFA is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide TFA, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide TFA has Survodutide (BI 456906) TFA is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide TFA, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide TFA has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake[1]... Read More |